Hanmi Pharmaceutical's first domestically developed GLP-1 obesity drug has won regulatory approval in Korea, setting up ...

The prevention authorities have caught a number of cases of illegally distributing or selling obesity treatments such as "Munzaro" and "Wigobi," which are in short supply through used trading platform ...

Pediatric obesity specialists in Korea called Monday for insurance-covered counseling, referral and follow-up care for ...

Hanmi Pharmaceutical’s obesity drug Epe has won regulatory approval and is set to launch by year-end, becoming South Korea’s ...

As obesity treatments are gaining explosive popularity around the world, competition over them is becoming more complicated.

휴온스가 자체 개발 중인 신약 후보물질의 비임상 연구결과 2건이 최신혁신초록(LBA)으로 각각 선정됐다고 2일 밝혔다. LBA는 학계에 영향력이 높을 것으로 기대되는 최신 연구 결과를 공유하기 위한 특별 발표 세션이다.

It turns out that obesity may be much more complicated than we thought, with the condition potentially existing in up to 11 forms, each caused by distinct biological pathways. “It’s not just about the ...

A group of global experts is proposing a new way to define and diagnose obesity, reducing the emphasis on the controversial body mass index and hoping to better identify people who need treatment for ...

Metabolically healthy obesity is defined as having a BMI over 30 without the presence of metabolic syndrome factors such as high blood pressure, cardiovascular disease, type 2 diabetes, and high ...

Major medical organizations consider obesity a chronic disease, while some medical professionals and associations may disagree. Obesity may increase the chance of developing health conditions like ...

Obesity can increase pressure on the joints, which may increase wear and tear. This, in turn, may raise the risk of osteoarthritis (OA) or hasten its progress. According to a 2022 review article, ...